Omalizumab therapy for treatment of recalcitrant chronic spontaneous urticaria in an Asian population.
Kulthanan, Kanokvalai
Omalizumab therapy for treatment of recalcitrant chronic spontaneous urticaria in an Asian population. [electronic resource] - The Journal of dermatological treatment Mar 2017 - 160-165 p. digital
Publication Type: Journal Article
1471-1753
10.1080/09546634.2016.1200710 doi
Adult
Anti-Allergic Agents--administration & dosage
Antibodies, Monoclonal, Humanized--therapeutic use
Chronic Disease
Cyclosporine--therapeutic use
Drug Administration Schedule
Drug Therapy, Combination
Female
Histamine H1 Antagonists--administration & dosage
Humans
Male
Middle Aged
Omalizumab--administration & dosage
Prednisolone--therapeutic use
Retrospective Studies
Severity of Illness Index
Treatment Outcome
Urticaria--drug therapy
Omalizumab therapy for treatment of recalcitrant chronic spontaneous urticaria in an Asian population. [electronic resource] - The Journal of dermatological treatment Mar 2017 - 160-165 p. digital
Publication Type: Journal Article
1471-1753
10.1080/09546634.2016.1200710 doi
Adult
Anti-Allergic Agents--administration & dosage
Antibodies, Monoclonal, Humanized--therapeutic use
Chronic Disease
Cyclosporine--therapeutic use
Drug Administration Schedule
Drug Therapy, Combination
Female
Histamine H1 Antagonists--administration & dosage
Humans
Male
Middle Aged
Omalizumab--administration & dosage
Prednisolone--therapeutic use
Retrospective Studies
Severity of Illness Index
Treatment Outcome
Urticaria--drug therapy